[go: up one dir, main page]

PL2067779T3 - Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne - Google Patents

Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne

Info

Publication number
PL2067779T3
PL2067779T3 PL09153379T PL09153379T PL2067779T3 PL 2067779 T3 PL2067779 T3 PL 2067779T3 PL 09153379 T PL09153379 T PL 09153379T PL 09153379 T PL09153379 T PL 09153379T PL 2067779 T3 PL2067779 T3 PL 2067779T3
Authority
PL
Poland
Prior art keywords
production
tiotropium salts
formulas containing
medicinal formulas
medicinal
Prior art date
Application number
PL09153379T
Other languages
English (en)
Inventor
Rolf Banholzer
Peter Sieger
Waldemar Pfrengle
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530660&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2067779(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL2067779T3 publication Critical patent/PL2067779T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/10Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09153379T 2003-11-03 2004-10-29 Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne PL2067779T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03025075 2003-11-03
EP04791028A EP1682541B1 (de) 2003-11-03 2004-10-29 Verfahren zur herstellung von tiotropiumsalzen
EP09153379.4A EP2067779B9 (de) 2003-11-03 2004-10-29 Tiotropiumsalze, Verfahren zu deren Herstellung und Arzneimittelformulierungen diese enthaltend

Publications (1)

Publication Number Publication Date
PL2067779T3 true PL2067779T3 (pl) 2013-09-30

Family

ID=34530660

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09153379T PL2067779T3 (pl) 2003-11-03 2004-10-29 Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
PL04791028T PL1682541T3 (pl) 2003-11-03 2004-10-29 Sposób wytwarzania soli tiotropium

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL04791028T PL1682541T3 (pl) 2003-11-03 2004-10-29 Sposób wytwarzania soli tiotropium

Country Status (34)

Country Link
US (1) US8686148B2 (pl)
EP (3) EP2336126A1 (pl)
JP (1) JP5165244B2 (pl)
KR (1) KR20060117334A (pl)
CN (3) CN102070630B (pl)
AR (1) AR046317A1 (pl)
AT (1) ATE460414T1 (pl)
AU (1) AU2004285683C1 (pl)
BR (1) BRPI0416136A (pl)
CA (1) CA2544348A1 (pl)
CO (1) CO5690553A2 (pl)
CY (2) CY1110048T1 (pl)
DE (1) DE502004010885D1 (pl)
DK (2) DK1682541T3 (pl)
EA (1) EA012326B1 (pl)
ES (2) ES2342468T3 (pl)
HR (1) HRP20100149T1 (pl)
IL (1) IL175023A (pl)
ME (1) ME00361B (pl)
MX (1) MXPA06004697A (pl)
MY (1) MY143364A (pl)
NO (1) NO335814B1 (pl)
NZ (1) NZ547276A (pl)
PE (1) PE20050446A1 (pl)
PL (2) PL2067779T3 (pl)
PT (2) PT2067779E (pl)
RS (2) RS51758B (pl)
SG (1) SG137859A1 (pl)
SI (2) SI2067779T1 (pl)
TW (2) TWI363758B (pl)
UA (1) UA82413C2 (pl)
UY (1) UY28590A1 (pl)
WO (1) WO2005042526A1 (pl)
ZA (1) ZA200602342B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682543B1 (de) * 2003-11-03 2010-08-18 Boehringer Ingelheim International Gmbh Verfahren zur herstellung neuer tiotropiumsalze
CN102070630B (zh) 2003-11-03 2013-04-17 贝林格尔.英格海姆国际有限公司 结晶噻托碘铵、包含该结晶噻托碘铵的药物制剂及其用途
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
NZ564697A (en) * 2005-06-15 2010-04-30 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005035112A1 (de) * 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CN102731494A (zh) 2005-12-19 2012-10-17 西科尔公司 噻托溴铵的新形式及其制备方法
EP1971332B1 (en) * 2006-01-04 2011-03-09 Boehringer Ingelheim International GmbH Use of tiotropium salts in the treatment of moderate persistent asthma
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
CZ201241A3 (cs) 2012-01-20 2013-07-31 Zentiva, K.S. Nové polymorfní formy tiotropium jodidu a zpusob jejich prípravy
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
JP6042197B2 (ja) * 2012-12-11 2016-12-14 エア・ウォーター株式会社 肺障害治療剤

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2597329A (en) 1947-08-06 1952-05-20 Merck & Co Inc Process for anion exchange of thiamin salts
US3551492A (en) * 1967-10-31 1970-12-29 Ciba Geigy Corp N,n'-diaminoalkoxy-benzyl-diamino-alkanes and the salts thereof
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
JPS6165885A (ja) * 1984-09-07 1986-04-04 Tanabe Seiyaku Co Ltd 新規合成中間体及びその製法
AT396872B (de) 1985-07-30 1993-12-27 Glaxo Group Ltd Gerät zur verabreichung von medikamenten in pulverform
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP3302647B2 (ja) * 1992-04-24 2002-07-15 小野薬品工業株式会社 フェニルアルカン酸エステルの塩酸塩、およびその製造方法
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
JP4023086B2 (ja) * 1999-12-27 2007-12-19 和光純薬工業株式会社 スルホニウム塩化合物
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
ES2228965T3 (es) 2000-10-12 2005-04-16 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Monohidrato cristalino de bromuro de tiotropio, procedimiento para su preparacion y su uso para la produccion de un medicamento.
BR0107304A (pt) 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
UA78690C2 (uk) * 2000-10-31 2007-04-25 Boehringer Ingelheim Pharma Лікарська композиція для інгаляційного застосування у вигляді розчину із сіллю тіотропію
US20020137764A1 (en) 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020183292A1 (en) 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
US20020111363A1 (en) 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193393A1 (en) 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20020193392A1 (en) 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
DE10061877A1 (de) * 2000-12-12 2002-06-13 Basf Ag Verfahren zur Herstellung wässriger Copolymerisatdispersionen von Copolymerisaten aus Kohlenmonoxid und wenigstens einer olefinisch ungesättigten Verbindung
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
DE10111843A1 (de) 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
US20020193394A1 (en) * 2001-03-13 2002-12-19 Bernd Disse Compounds for treating inflammatory diseases
US20030070679A1 (en) 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
GB0203193D0 (en) 2002-02-11 2002-03-27 Pfizer Ltd Nicotinamide derivatives useful as pde4 inhibitors
US20030229227A1 (en) * 2002-03-16 2003-12-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New difurylglycolic acid esters, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
BR0308984A (pt) 2002-04-04 2005-02-09 Boehringer Ingelheim Pharma Formulações em pó adequadas para inalação
UA80123C2 (en) 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
DE10216036A1 (de) 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
US6908055B2 (en) 2003-02-27 2005-06-21 Tandberg Data Asa System for extracting magnetic recording tape from a tape cartridge for engagement with a take-up reel
US20050030040A1 (en) * 2003-06-27 2005-02-10 Mitch Budniak Electrical testing device having voice annunciator
EP1682543B1 (de) 2003-11-03 2010-08-18 Boehringer Ingelheim International Gmbh Verfahren zur herstellung neuer tiotropiumsalze
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
CN102070630B (zh) 2003-11-03 2013-04-17 贝林格尔.英格海姆国际有限公司 结晶噻托碘铵、包含该结晶噻托碘铵的药物制剂及其用途
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303270L (sv) 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
NZ564697A (en) 2005-06-15 2010-04-30 Boehringer Ingelheim Int Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
MXPA06004697A (es) 2006-07-05
RS51758B (sr) 2011-12-31
AU2004285683B2 (en) 2011-04-21
PT1682541E (pt) 2010-04-14
ME00361B (me) 2011-10-10
EP1682541B1 (de) 2010-03-10
ZA200602342B (en) 2007-06-27
NO20061440L (no) 2006-07-12
IL175023A (en) 2011-02-28
CN102070630A (zh) 2011-05-25
EP2336126A1 (de) 2011-06-22
TWI435876B (zh) 2014-05-01
US8686148B2 (en) 2014-04-01
UA82413C2 (uk) 2008-04-10
WO2005042526A1 (de) 2005-05-12
TW200526653A (en) 2005-08-16
AR046317A1 (es) 2005-11-30
NZ547276A (en) 2009-08-28
HK1153409A1 (en) 2012-03-30
DE502004010885D1 (de) 2010-04-22
HRP20100149T1 (hr) 2010-04-30
CO5690553A2 (es) 2006-10-31
HK1099748A1 (zh) 2007-08-24
MEP51308A (en) 2011-05-10
SG137859A1 (en) 2007-12-28
DK2067779T3 (da) 2013-07-29
AU2004285683A1 (en) 2005-05-12
PE20050446A1 (es) 2005-08-02
TW201231465A (en) 2012-08-01
ES2422729T3 (es) 2013-09-13
JP5165244B2 (ja) 2013-03-21
NO335814B1 (no) 2015-02-23
EP2067779B9 (de) 2013-10-16
EP2067779B1 (de) 2013-04-24
CN102070630B (zh) 2013-04-17
PT2067779E (pt) 2013-07-25
MY143364A (en) 2011-04-29
DK1682541T3 (da) 2010-06-28
EA200600886A1 (ru) 2006-10-27
HK1129111A1 (en) 2009-11-20
EA012326B1 (ru) 2009-08-28
JP2007509893A (ja) 2007-04-19
US20050131007A1 (en) 2005-06-16
UY28590A1 (es) 2005-06-30
RS20060292A (sr) 2008-08-07
CN100549010C (zh) 2009-10-14
IL175023A0 (en) 2006-08-20
CY1114157T1 (el) 2016-08-31
ATE460414T1 (de) 2010-03-15
PL1682541T3 (pl) 2010-08-31
AU2004285683C1 (en) 2011-09-08
SI2067779T1 (sl) 2013-08-30
CN101407514B (zh) 2013-05-29
KR20060117334A (ko) 2006-11-16
CN101407514A (zh) 2009-04-15
BRPI0416136A (pt) 2007-01-02
CY1110048T1 (el) 2015-01-14
EP2067779A1 (de) 2009-06-10
TWI363758B (en) 2012-05-11
ES2342468T3 (es) 2010-07-07
EP1682541A1 (de) 2006-07-26
SI1682541T1 (sl) 2010-06-30
CN1882582A (zh) 2006-12-20
CA2544348A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
IL176916A0 (en) Aryl substituted heterocycles, method for production and use thereof as medicaments
HUS1400056I1 (hu) Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
IL176913A0 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
EP1706412A4 (en) Novel pyridine derivatives, process for their preparation and pharmaceutical composition containing them
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
PL377741A1 (pl) Pochodne diarylocykloalkilowe, sposób ich wytwarzania i ich zastosowanie jako środka leczniczego
IL179758A (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments
ZA200510378B (en) Substituted thiazole-benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
PL376399A1 (pl) Nowe związki pirydopirymidynowe, proces ich wytwarzania i zawierające je mieszanki farmaceutyczne
IL175127A0 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
PL2067779T3 (pl) Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
IL170175A (en) Methods for producing cyclic benzamidine derivatives
PL371317A1 (pl) Pochodne acylo-3-karboksyfenylo-mocznika, sposób ich wytwarzania i ich zastosowanie
PL377755A1 (pl) Cykloalkilo-podstawione pochodne kwasów alkanowych, sposób ich wytwarzania i ich zastosowanie, jako środka leczniczego
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
EP1693067A4 (en) PHARMACEUTICAL COMPOSITION AGAINST HERPES, METHOD FOR THE PREPARATION OF A DOSAGE FORM AND METHOD FOR THE APPLICATION THEREFOR
HUP0302440A3 (en) Aminoquinoline derivatives, process for producing them and pharmaceutical compositions containing them
ZA200601300B (en) Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament, and method for the production thereof
ZA200601360B (en) Pharmaceutical formulation containing an LTB4 antagonist, method for the production thereof, and use thereof